维生素D状态和化疗诱导的外围神经病变:一个范围审查
Daniel A Cubillos-Rojas1, Felipe Duarte-Zambrano1, Jorge A Barrero1
1Universidad Nacional de Colombia, Sede Bogotá, Facultad de Medicina, Departamento de Ciencias Fisiológicas, División de Lípidos y Diabetes, Bogotá, Colombia.
Nutrition and health
|December 8, 2025
概括
低维生素D (VD) 水平与化学疗法诱导的外周神经病变 (CIPN) 的更高风险和严重程度有关. 这表明VD可能对这种常见的化疗副作用起着保护作用.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 营养科学 营养科学
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 是常见癌症治疗的显著不良影响.
- 营养状况,特别是维生素D (VD) 水平,可能会影响CIPN的发展和严重程度.
研究的目的:
- 在接受化疗的患者中,系统地审查和汇编有关维生素D状态和CIPN之间的关联的证据.
主要方法:
- 根据PRISMA-ScR指南进行了范围审查.
- 搜索包括主要数据库 (MEDLINE,Embase,科学网,Scopus,Cochrane) 相关的初级研究.
- 审查中包括了11项观察性研究.
主要成果:
- 在接受帕克利塔塞尔 (乳腺/宫癌),博尔特佐米布/塔利多米德/莱纳利多米德 (多发性骨髓瘤) 和氧沙利 (胃肠道瘤) 的患者中,低水平的VD与较高的CIPN发病率和风险有关.
- 血管疾病缺乏似乎是某些癌症患者群体中CIPN发展的预测因素.
结论:
- 低血清VD水平与CIPN.的风险和严重程度增加有关.
- 血管疾病的潜在神经保护性,神经再生性和抗炎性质可能会减轻CIPN.
- 需要进一步的研究,包括分层的RCT,以确认临床影响和标准化静脉疾病评估.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
524
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
524
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
790
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
790
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
576
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
576
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
653
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
653
Peripheral Artery Disease IV: Nursing Management
321
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
321

